The Centers for Disease Control and Prevention (CDC) says that data collected on the Pfizer-BioNTech COVID-19 vaccine merits an investigation into potential stroke risks for people aged 65 and older.
CDC press release:
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/bivalent-boosters.html